@article{06f7bd00c0e846d3917f1c2541f63ed9,
title = "Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma",
abstract = "Cutaneous T-cell lymphoma is a heterogeneous group of lymphomas characterized by the accumulation of malignant T cells in the skin. The molecular and cellular etiology of this malignancy remains enigmatic, and what role antigenic stimulation plays in the initiation and/or progression of the disease remains to be elucidated. Deep sequencing of the tumor genome showed a highly heterogeneous landscape of genetic perturbations, and transcriptome analysis of transformed T cells further highlighted the heterogeneity of this disease. Nonetheless, using data harvested from high-throughput transcriptional profiling allowed us to develop a reliable signature of this malignancy. Focusing on a key cytokine signaling pathway previously implicated in cutaneous T-cell lymphoma pathogenesis, JAK/STAT signaling, we used conditional gene targeting to develop a fully penetrant small animal model of this disease that recapitulates many key features of mycosis fungoides, a common variant of cutaneous T-cell lymphoma. Using this mouse model, we show that T-cell receptor engagement is critical for malignant transformation of the T lymphocytes and that progression of the disease is dependent on microbiota.",
author = "Fanok, {Melania H.} and Amy Sun and Fogli, {Laura K.} and Vijay Narendran and Miriam Eckstein and Kasthuri Kannan and Igor Dolgalev and Charalampos Lazaris and Adriana Heguy and Laird, {Mary E.} and Sundrud, {Mark S.} and Cynthia Liu and Jeff Kutok and Lacruz, {Rodrigo S.} and Latkowski, {Jo Ann} and Iannis Aifantis and Niels {\O}dum and Hymes, {Kenneth B.} and Swati Goel and Koralov, {Sergei B.}",
note = "Funding Information: Work in SBK{\textquoteright}s laboratory was supported by the National Institutes of Health (NIH) (R01HL125816), the NYUCI Pilot Grant, the Feinberg Lymphoma Research Grant, and grants from the Spatz Charitable Foundation, the Cutaneous Lymphoma Foundation, the Concern Foundation, and Hirschl/Weill-Caulier Trust. Additionally, MHF was supported by NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases award number F31AR070094. AS was supported by the William Randolph Hearst Foundation. AS and MHF were supported by NIH training grants T32-GM007308, T32-CA009161, and T32-AI 100853-3. LKF was supported by NIH F31 CA171596-02. The New York University Experimental Pathology Immunohistochemistry Core Laboratory is supported in part by the Laura and Isaac Perlmutter Cancer Center support grant, NIH/National Cancer Institute P30CA016087 and NIH S10 grants, and NIH/Office of Research Infrastructure Programs S10OD01058 and S10OD018338. N{\O} was supported by the Novo Nordic Foundation Tandem program and the Danish Cancer Society Knaek Cancer Program. ME and RSL were supported by R01 National Institute of Dental and Craniofacial Research (DE025639) Publisher Copyright: {\textcopyright} 2017 The Authors",
year = "2018",
month = may,
doi = "10.1016/j.jid.2017.10.028",
language = "English (US)",
volume = "138",
pages = "1116--1125",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "5",
}